BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16619570)

  • 41. Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: a Gynecologic Oncology Group study in United States.
    Liao SY; Rodgers WH; Kauderer J; Bonfiglio TA; Walker JL; Darcy KM; Carter R; Hatae M; Levine L; Spirtos NM; Stanbridge EJ
    Int J Cancer; 2009 Nov; 125(10):2434-40. PubMed ID: 19670419
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human papillomavirus detection by PCR assay in a large series of high-grade squamous intraepithelial lesions with cytohistological correlation and follow-up.
    Lerma Puertas E; Otal Salaverri C; Ríos Martín JJ; Sánchez Gómez A; Jiménez Caraballo A; González-Cámpora R
    Acta Cytol; 2011; 55(5):426-32. PubMed ID: 21986169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human papillomavirus detection by hybrid capture II and residual or recurrent high-grade squamous cervical intraepithelial neoplasia after large loop excision of the transformation zone (LLETZ).
    Sarian LO; Derchain SF; Pittal Dda R; Andrade LA; Morais SS; Figueiredo PG
    Tumori; 2005; 91(2):188-92. PubMed ID: 15948550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
    Aleksioska-Papestiev I; Chibisheva V; Micevska M; Dimitrov G
    Med Arch; 2018 Feb; 72(1):26-30. PubMed ID: 29416214
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Telomerase assay and HPV 16/18 typing as adjunct to conventional cytological cervical cancer screening.
    Ngan HY; Cheung AN; Liu SS; Liu KL; Tsao SW
    Tumour Biol; 2002; 23(2):87-92. PubMed ID: 12065846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear.
    Monsonego J; Bohbot JM; Pollini G; Krawec C; Vincent C; Merignargues I; Haroun F; Sednaoui P; Monfort L; Dachez R; Syrjänen K
    Gynecol Oncol; 2005 Oct; 99(1):160-8. PubMed ID: 16023184
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of Yes-associated protein in cervical squamous epithelium lesions.
    Xiao H; Wu L; Zheng H; Li N; Wan H; Liang G; Zhao Y; Liang J
    Int J Gynecol Cancer; 2014 Nov; 24(9):1575-82. PubMed ID: 25304677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia.
    Quek SC; Lim BK; Domingo E; Soon R; Park JS; Vu TN; Tay EH; Le QT; Kim YT; Vu BQ; Cao NT; Limson G; Pham VT; Molijn A; Ramakrishnan G; Chen J
    Int J Gynecol Cancer; 2013 Jan; 23(1):148-56. PubMed ID: 23221730
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Triage of atypical squamous cells of undetermined significance with hybrid capture II: colposcopy and histologic human papillomavirus correlation.
    Lonky NM; Felix JC; Naidu YM; Wolde-Tsadik G
    Obstet Gynecol; 2003 Mar; 101(3):481-9. PubMed ID: 12636951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of HPV subtypes not covered by the nine-valent vaccine in patients with CIN 2-3 and cervical squamous cell carcinoma.
    Ma MJ; Wang YN; Zhu JF; Wang XY; Jin YB; Liu XN; Wu SF; Yang YB
    Curr Probl Cancer; 2021 Dec; 45(6):100761. PubMed ID: 34154817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia?
    Tracht JM; Davis AD; Fasciano DN; Eltoum IA
    Cancer Cytopathol; 2017 Oct; 125(10):795-805. PubMed ID: 28817235
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic significance of high-risk HPV persistence after laser CO2 conization for high-grade CIN: a prospective clinical study.
    Fallani MG; Penna C; Marchionni M; Bussani C; Pieralli A; Andersson KL; Fambrini M
    Eur J Gynaecol Oncol; 2008; 29(4):378-82. PubMed ID: 18714574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low-Risk Human Papillomavirus Types in Cervical Intraepithelial Neoplasia 2-3 and in Invasive Cervical Cancer Patients.
    Siegler E; Reichman Y; Kugelman N; Mackuli L; Lavie O; Ostrovsky L; Shaked-Mishan P; Segev Y
    J Low Genit Tract Dis; 2019 Oct; 23(4):248-252. PubMed ID: 31592971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Up-regulation of plasminogen activator inhibitor-2 is associated with high-risk HPV and grade of cervical lesion at baseline but does not predict outcomes of high-risk HPV infections or incident CIN.
    Syrjänen S; Naud P; Sarian L; Derchain S; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Hammes LS; Costa S; Syrjänen K
    Am J Clin Pathol; 2009 Dec; 132(6):883-92. PubMed ID: 19926580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results.
    Guo M; Gong Y; Wang J; Dawlett M; Patel S; Liu P; Bevers TB; Sneige N
    Cancer Cytopathol; 2013 Feb; 121(2):79-85. PubMed ID: 23225501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Association between high-risk human papillomavirus DNA load and different histological grades of cervical neoplasia].
    Zhao FH; Hu SY; Wang SM; Chen F; Zhang X; Zhang WH; Pan QJ; Qiao YL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):565-70. PubMed ID: 19954065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determination of features indicating progression in atypical squamous cells with undetermined significance: human papillomavirus typing and DNA ploidy analysis from liquid-based cytologic samples.
    Bollmann R; Méhes G; Torka R; Speich N; Schmitt C; Bollmann M
    Cancer; 2003 Apr; 99(2):113-7. PubMed ID: 12704691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
    BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
    Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
    Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human papillomavirus viral load in predicting high-grade CIN in women with cervical smears showing only atypical squamous cells or low-grade squamous intraepithelial lesion.
    Santos AL; Derchain SF; Martins MR; Sarian LO; Martinez EZ; Syrjänen KJ
    Sao Paulo Med J; 2003 Nov; 121(6):238-43. PubMed ID: 14989139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.